Events Partner Content The COVID-19 Effect: How Pharma Can Adapt to the Evolving Pa... Virtual event highlighting the critical patient POV
Events Partner Content Patient-to-Patient Supply for Cell Immunotherapies Summit Achieving Standardization & Operational Excellence in Vein-to-Vein Supply
Partner Content Partner Content Playing an Active Role in Treatment Yields More Confidence i... What does it mean to play an active role in treatment?
Partner Content Partner Content People with Chronic Conditions Concerned About “Returning to... People living with chronic conditions remain cautious
Partner Content Partner Content Registration opens for Wearable Injectors & Connected Device... Wearable Injectors and Connected Devices
News GSK gets second cancer drug approval from Nuvalent buy The FDA has cleared GSK's ALK inhibitor Nelkarmi for a form of lung cancer, the second product from its $10.6bn acquisition of Nuvalent.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.